Antisense oligonucleotide inhibitors of isozymes of protein kinase C: In vitro and in vivo activity, and clinical development as anti-cancer therapeutics

Anti-Cancer Drug Design

Volumn 12, Issue 5, 1997, Pages 315-326

  McGraw, K ^a   McKay, R ^a   Miraglia, L ^a   Boggs, R T ^a   Pribble, J P ^a   Muller, M ^b   Geiger, T ^b   Fabbro, D ^b   Dean, N M ^b  

^a ISIS PHARMACEUTICALS   (United States)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ISIS 3521; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; DRUG TARGETING; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; HUMANS; ISOENZYMES; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C;

EID: 0030847821     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. AGRAWAL, S., MAYRAND, SH , ZAMECNIK, P.C. & PEDERSON, T. (1990). Proceedings of the National Academy of Sciences, USA, 87, 1401.
2. AHMED, S., MINETA, T., MARTUZA, R.L. & GLAZER, R.I. (1994). Neurosurgery, 35, 904.
3. ALTMANN, K.-H., FABBRO, D., DEAN, N.M., GEIGER, T., MONIA, B.P., MULLER, M. & NICKLIN, P. (1996). Biochemical Society Transactions, 24, 630.
4. ASAOKA, Y., NAKAMURA, S., YOSHIDA, K. & NISHIZUKA, Y. (1992). Trends in Biochemical Sciences, 17, 414.
5. BALTUCH, G., COULDWELL, W., VILLEMURE, J. & YONG, V. (1993). Neurosurgery, 33, 495.
6. BASU, A. (1993). Pharmacology and Therapeutics, 59, 257.
7. BENNETT, C.F. (1995). In Delivery Strategies for Antisense Oligonucleotide Therapeutics. Akhtar, S. (ed.), p. 223. CRC Press: Boca Raton, FL.
8. BENNETT, CF, CHIANG, M.-Y., CHAN, H., SHOEMAKER, J.E.E. & MIRABELLI, C.K. (1992). Molecular Pharmacology, 41, 1023.
9. BENNETT, C.F., CONDON, T., GRIMM, S., CHAN, H. & CHIANG, M.-Y. (1994). Journal of Immunology, 152, 3530.
10. BORNER, C., EPPENBERGER, U , WYSS, R. & FABBRO, D. (1988). Proceedings of the National Academy of Sciences, USA, 85, 2110.
11. BOYD, M. (1993). In Current Therapy in Oncology. Neiderhuber, J.E. (ed.), p. 11. Decker: Philadelphia, PA.
12. CROOKE, S.T. (1995). Therapeutic Applications of Oligonucleotides. R.G. Landes Company: Austin, TX.
13. CROOKE, S.T & BENNETT, C.F. (1996). Annual Review of Pharmacology and Toxicology, 36, 107.
14. CROOKE, S.T. & LEBLEU, B. (1993). Antisense Research and Applications. CRC Press: Boca Raton, FL.
15. DEAN, N.M., MCKAY, R., CONDON, T.P. & BENNETT, C.F (1994). Journal of Biological Chemistry, 269, 16416.
16. DEAN, N.M., MCKAY, R., MIRAGLIA, L., HOWARD, R., COOPER, S , GIDDINGS, J , NICKLIN, P., MEISTER, L., ZEIL, R., GEIGER, T., MULLER, M. & FABBRO, D (1996a). Cancer Research, 56, 3499.
17. DEAN, N.M , MCKAY, R., MIRAGLIA, L., GEIGER, T, MULLER, M., FABBRO, D. & BENNETT, C F (1996b). Biochemical Society Transactions, 24, 623.
18. DEKKER, L.V & PARKER, P.J. (1994). Trends in Biochemical Sciences, 19, 73.
19. DOLNICK, B.J. (1991). Cancer Investigations, 9, 185.
20. DUYSTER, J., SCHWENDE, H., FITZKE, E , HIDAKA, H. & DIETER, P. (1993). Biochemical Journal, 292, 203.
21. GESCHER, A & DALE, I. L. (1995). Anti-Cancer Drug Design, 4, 93.
22. GILES, R.V. & TIDD, D.M. (1992a). Nucleic Acids Research, 20, 763.
23. GILES, R.V. & TIDD, D.M. (1992b). Anti-Cancer Drug Design, 7, 37.
24. HO, S.P., BRITTON, D.H. O., STONE, B A., BEHRENS, D.L., LEFFET, L.M., HOBBS, F W., MILLER, J A. & TRAINOR, G. L. (1996). Nucleic Acids Research, 24, 1901.
25. HOUSEY, G.M., JOHNSON, M D., HSIAO, WL W. O'BRIAN, C A., MURPHY, J.P., KIRSHMEIER, P. & WEINSTEIN, I B. (1988). Cell, 52, 343.
26. HUG, H. & SARRE, T.F. (1993). Biochemical Journal, 291, 329.
27. INOUE, H., HAYASE, Y., IWAI, S. & OHTSUKE, E. (1987). FEBS Letters, 215, 327.
28. LEE, Y.-S., DLUGOSZ, A.A., MCKAY, R , DEAN, N M. & YUSPA, S H. (1996). Molecular Carcinogenesis, in press.
29. MCKAY, R.M., CUMMINS, L.L , GRAHAM, M.J., LESNICK, E.A., OWENS, S.R., WINNIMAN, M. & DEAN, N.M. (1996). Nucleic Acids Research, 24, 411.
30. MINANA, M., FELIPO, V., CORTES, F. & GRISOLIA, s. (1991). FEBS Letters, 2, 60.
31. MONIA, B P., LESNIK, E.A., GONZALEZ, C , LIMA, W.F., MCGEE, D., GUINOSSO, C J, KAWASAKI, A.M., COOK, P.D. & FREIER, S.M. (1993). Journal of Biological Chemistry, 268, 14514.
32. MONIA, B., JOHNSTON, J.F , SASMOR, H. & CUMMINS, L.L. (1996). Journal of Biological Chemistry, 24, 14533.
33. NISHIZUKA, Y. (1992). Science, 258, 607.
34. O'BRIAN, C., VOGEL, V.G., SINGLETARY, S.E. & WARD, N E. (1989). Cancer Research, 49, 3215.
35. O'BRIAN, C.A. & KUO, J.F. (1994). In Protein Kinase C. Kuo, J.F. (ed.), p. 96. Oxford University Press: Oxford.
36. PERSONS, D.A., WILKISON, W.O., BELL, R.M. & FINN, O.J. (1988). Cell, 52, 447.
37. WAKITA, T. & WANDS, JR (1994). Journal of Biological Chemistry, 269, 14205.
38. WAYS, D.K., KUKOLY, C.A., DEVENTE, J., HOOKER, J.L., BRYANT, W.O., POSEKANY, K J , FLETCHER, D.J., COOK, P.P. & PARKER, P.P. (1995). Journal of Clinical Investigation, 95, 1906.
39. WEINSTEIN, B I. (1991). Cancer Research (Supplement), 51, 5080s.
40. YAZAKI, T., AHMAD, S , CHAHLAVI, A., ZYLBER-KATZ, E., DEAN, N.M., RABKIN, S.D., MARTUZA, R.L. & GLAZER, R I. (1996). Molecular Pharmacology, 50, 236.
41. YOUNG, S., PARKER, P, ULLRICH, A. & STABEL, S. (1987). Biochemical Journal, 244, 775.
42. YUSPA, S.H. (1994). Cancer Research, 54, 1178.